209 related articles for article (PubMed ID: 11792706)
1. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.
Mansky KC; Sankar U; Han J; Ostrowski MC
J Biol Chem; 2002 Mar; 277(13):11077-83. PubMed ID: 11792706
[TBL] [Abstract][Full Text] [Related]
2. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).
Bronisz A; Carey HA; Godlewski J; Sif S; Ostrowski MC; Sharma SM
J Biol Chem; 2014 Jan; 289(1):326-34. PubMed ID: 24257758
[TBL] [Abstract][Full Text] [Related]
3. Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant.
Carey HA; Bronisz A; Cabrera J; Hildreth BE; CuitiƱo M; Fu Q; Ahmad A; Toribio RE; Ostrowski MC; Sharma SM
J Cell Physiol; 2016 Mar; 231(3):630-40. PubMed ID: 26218069
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
[TBL] [Abstract][Full Text] [Related]
5. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
6. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
Matsumoto M; Sudo T; Saito T; Osada H; Tsujimoto M
J Biol Chem; 2000 Oct; 275(40):31155-61. PubMed ID: 10859303
[TBL] [Abstract][Full Text] [Related]
7. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
Kwak HB; Lee SW; Jin HM; Ha H; Lee SH; Takeshita S; Tanaka S; Kim HM; Kim HH; Lee ZH
Blood; 2005 Apr; 105(7):2963-9. PubMed ID: 15585657
[TBL] [Abstract][Full Text] [Related]
8. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression.
So H; Rho J; Jeong D; Park R; Fisher DE; Ostrowski MC; Choi Y; Kim N
J Biol Chem; 2003 Jun; 278(26):24209-16. PubMed ID: 12695521
[TBL] [Abstract][Full Text] [Related]
9. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
Lin J; Lee D; Choi Y; Lee SY
Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
[TBL] [Abstract][Full Text] [Related]
12. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
13. A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide.
Rossa C; Liu M; Kirkwood KL
J Periodontal Res; 2008 Apr; 43(2):201-11. PubMed ID: 18302623
[TBL] [Abstract][Full Text] [Related]
14. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
Ariyoshi W; Takahashi T; Kanno T; Ichimiya H; Takano H; Koseki T; Nishihara T
J Biol Chem; 2005 May; 280(19):18967-72. PubMed ID: 15757905
[TBL] [Abstract][Full Text] [Related]
16. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CD26 signaling inhibits human osteoclast development.
Nishida H; Suzuki H; Madokoro H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
J Bone Miner Res; 2014 Nov; 29(11):2439-55. PubMed ID: 24821427
[TBL] [Abstract][Full Text] [Related]
18. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.
Li X; Udagawa N; Itoh K; Suda K; Murase Y; Nishihara T; Suda T; Takahashi N
Endocrinology; 2002 Aug; 143(8):3105-13. PubMed ID: 12130576
[TBL] [Abstract][Full Text] [Related]
19. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.
Komarova SV; Pereverzev A; Shum JW; Sims SM; Dixon SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2643-8. PubMed ID: 15695591
[TBL] [Abstract][Full Text] [Related]
20. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.
Matsumoto M; Kogawa M; Wada S; Takayanagi H; Tsujimoto M; Katayama S; Hisatake K; Nogi Y
J Biol Chem; 2004 Oct; 279(44):45969-79. PubMed ID: 15304486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]